Dr. Daniela Zizioli is a confirmed researcher at the University of Brescia, Section Biotechnology. She obtained a degree with full marks in biological sciences from the University of Milan in 1990. She obtained her Ph.D. in cellular and molecular biotechnology from the University of Brescia in 1997. She obtained a specialization diploma in biochemistry and clinical chemistry in 2000. From November 2000 to November 2004, she served as an unconfirmed researcher at the University of Brescia. Since December 2004, she has been proclaimed a confirmed researcher. The research topics addressed by Dr. Daniela Zizioli can be grouped as follows: (1) A zebrafish animal model for studying human pathologies. The pathologies studied include neurodegenerative pathologies, chronic myelogenous leukemia, pathologies involved in the synthesis of Coenzyme A, and intracellular vesicular traffic. As part of this line of research, knock-out animals obtained with recent CRISPR/Cas9 technology, knock-down animals obtained with morpholino technology, and transgenic animals are used. (2) Use of the zebrafish animal model to study the toxicity and mechanism of action of methylxanthines. (3) Use of the zebrafish animal model to study behavior.